Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vesicular pemphigoid vs dermatitis herpetiformis.

J Jawitz, V Kumar, T P Nigra

    Journal of the American Academy of Dermatology
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A strategy for monitoring and evaluating massive open online courses.

    Evaluation and program planning·2016
    Same author

    Streptomycin-oxytetracycline combined therapy; correlation between in vivo and in vitro trials.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    Further studies on retional in vitro bacterial sensitivity testing to nitrofurantoin.

    Antibiotics & chemotherapy (Northfield, Ill.)·2014
    Same author

    IgG4 as the predominant IgG subclass in pemphigoides gestationis.

    Journal of cutaneous pathology·2006
    Same author

    Complement-fixing properties of antinuclear antibodies distinguish drug-induced lupus from systemic lupus erythematosus.

    Lupus·2004
    Same author

    Linear IgA bullous dermatosis in one of two piroxicam-induced eruptions: a distinct direct immunofluorescence trend revealed by the literature.

    Journal of the American Academy of Dermatology·2001

    This study details a patient initially presenting with features of both dermatitis herpetiformis (DH) and bullous pemphigoid (BP). Over five years, the patient

    Area of Science:

    • Dermatology
    • Immunodermatology
    • Autoimmune blistering diseases

    Background:

    • Dermatitis herpetiformis (DH) and bullous pemphigoid (BP) are distinct autoimmune blistering diseases.
    • Distinguishing between DH and BP can be challenging due to overlapping clinical and histopathological features.
    • Immunofluorescence (IF) and serological markers are crucial for accurate diagnosis.

    Observation:

    • A patient presented with clinical signs of DH and histopathological findings suggestive of both DH and BP.
    • Initial immunofluorescence studies showed linear IgG and C3 deposits along the basement membrane zone (BMZ), with circulating BMZ antibodies, consistent with BP.
    • Over a five-year period, the patient's condition evolved.

    Findings:

    • The patient ultimately developed typical dermatitis herpetiformis, confirmed by characteristic histological findings (papillary edema, neutrophilic infiltrates).

    Related Experiment Videos

  • Subsequent IF studies revealed granular IgA deposits in dermal papillae, a hallmark of DH.
  • Antigliadin antibodies were detected in the serum, further supporting the diagnosis of DH.

    • Implications:

    • This case highlights the potential for diagnostic complexity and evolving presentation in autoimmune blistering diseases.
    • It underscores the importance of longitudinal follow-up and reassessment of diagnostic markers over time.
    • Understanding the diagnostic evolution from potential bullous pemphigoid to dermatitis herpetiformis aids in refining diagnostic criteria and patient management strategies.